血清FT3、cTnI、BNP对老年急性心力衰竭患者危险分层和预后预测的应用价值比较

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (607 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the application value of serum free triiodothyronine (FT3), cardiac troponin I (cTnI) and brain natriuretic peptide (BNP) in risk stratification and prognosis prediction of elderly patients with acute heart failure (AHF). Methods A retrospective study of 232 patients aged 65 and over with AHF in the First Affiliated Hospital of Guangzhou University of Chinese Medicine from October 2018 to March 2020 was performed. Clinical data of the patients were recorded and followed up for 90 days. According to the severity criteria, the patients were divided into critical group (92 cases) and non-critical group (140 cases). The general data of the critical group and the non-critical group were compared. Multivariate logistic regression analysis was used to evaluate the influencing factors of the critical severity of AHF patients, and receiver-operating characteristic curve was drawn to analyze the predictive effectiveness of relevant indicators for the critical severity of AHF patients. According to the survival within 90 days, patients were divided into death group (34 cases) and non-death group (198 cases). Compared with the general data of the death group and the non-death group, Cox regression was used to analyze the influence of related indicators on the all-cause death of AHF patients. Results The levels of FT3 and left ventricular ejection fraction (LVEF) in the critical group were lower than those in the non-critical group. The levels of creatinine, BNP, and cTnI in the critical group were higher than those in the non-critical group, the differences were statistically significant (P ＜ 0.05). The comparison of New York Heart Association (NYHA) cardiac function grading between the two groups showed statistical significance (P ＜ 0.05). Multivariate logistic regression analysis showed that FT3, LVEF and creatinine were the influencing factors for the severity of elderly AHF after adjusting for age, sex and body mass index (BMI) (P ＜ 0.01). The area under the curve (AUC) predicted by FT3 of critical group was 0.719, 95%CI: 0.653-0.786, sensitivity was 83%, specificity was 57%. cTnI predicted the AUC of critical group was 0.601, 95%CI: 0.526-0.675, sensitivity was 72%, specificity was 48%. BNP predicted the AUC of critical group was 0.623, 95%CI: 0.552-0.695, sensitivity was 69%, specificity was 56%. The level of FT3 in the death group was lower than that in the non-death group, and the level of cTnI was higher than that in the non-death group (P ＜ 0.05). Multivariate Cox regression analysis showed that FT3 and cTNI were the influencing factors of 90 d all-cause death in elderly patients with AHF after adjusting for age, sex, BMI, creatinine and NYHA cardiac function (P ＜ 0.01). Conclusion In terms of prognosis and prognosis, FT3, cTnI, and BNP have their own advantages and disadvantages, and FT3 is a better choice for elderly AHF patients with renal insufficiency.

Key words： Acute heart failure Risk stratification Prognosis Low T3 syndrome Free triiodothyronine

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Yu1 WANG Sudan2 LUO Yuanyuan3 WU Sihui3

Cite this article:

LIU Yu1 WANG Sudan2 LUO Yuanyuan3 WU Sihui3. Comparison of the value of serum FT3, cTnI and BNP in risk stratification and prognosis prediction to elderly patients with acute heart failure[J]. 中国医药导报, 2021, 18(26): 54-59.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I26/54

[1] Kurmani S，Squire I. Acute Heart Failure Definition，Classification and Epidemiology [J]. Curr Heart Fail Rep，2017， 14（5）：385-392.
[2] Sinnenberg L，Givertz MM. Acute heart failure [J]. Trends Cardiovasc Med，2020，30（2）：104-112.
[3] 李世军.老年心力衰竭流行病学和病理生理学及预后的研究进展[J].中华老年心脑血管杂志，2021，23（3）：318-320.
[4] Groenewegen A，Rutten FH，Mosterd A，et al. Epidemiology of heart failure [J]. Eur J Heart Fali，2020，52（15）：1641-1643.
[5] Farmakis D，Parissis J，Lekakis J，et al. Acute Heart Failure：Epidemiology，Risk Factors，and Prevention [J]. Rev Esp Cardiol（Engl Ed），2015，68（3）：245-248.
[6] Caprnda M，Zulli A，Shiwani HA，et al. The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure [J]. Clin Exp Pharmacol Physiol，2020，47（7）：1120-1133.
[7] Harrison N，Favot M，Levy P. The Role of Troponin for Acute Heart Failure [J]. Curr Heart Fail Rep，2019，16（1）：21-31.
[8] Cleland JGF，Teerlink JR，Davison BA，et al. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure—does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with T ezosentan in Acute heart failure Studies （VERIT AS）[J]. Eur J Heart Fali，2017，19（6）：739-747.
[9] Vale C，Neves JS，von Hafe M，et al. The Role of Thyroid Hormones in Heart Failure [J]. Cardiovasc Drugs Ther，2019，33（2）：179-188.
[10] Sato Y，Yoshihisa A，Kimishima Y，et al. Low T3 Syndrome Is Associated With High Mortality in Hospitalized Patients With Heart Failure [J]. J Card Fail，2019，25（3）：195-203.
[11] Pang PS，Collins SP，Gheorghiade M，et al. Acute Dyspnea and Decompensated HeartFailure [J]. Cardiol Clin，2018，36（1）：63-72.
[12] 中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.急性心力衰竭基层诊疗指南（2019年）[J].中国全科医师杂志，2019，18（10）：925-930.
[13] Demissei BG，Cotter G，Prescott MF，et al. A multimarker multi-time point-based risk stratification strategy in acute heart failure：results from the RELAX-AHF trial [J]. Eur J Heart Fail，2017，19（8）：1001-1010.
[14] Maiden MJ，Torpy DJ. Thyroid Hormones in Critical Illness [J]. Crit Care Clin，2019，35（2）：375-388.
[15] Asai K，Shirakabe A，Kiuchi K，et al. Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure [J]. Am J Cardiol，2020，125（3）：427-435.
[16] De Matteis G，Covino M，Burzo ML，et al. Prognostic role of hypothyroidism and low free-triiodothyronine levels in patients hospitalized with acute heart failure [J]. Intern Emerg Med，2021. DOI：10.1007/s11739-020-02582-y.
[17] Abdel-Moneim A，Gaber AM，Gouda s，et al. Relationship of thyroid dysfunction with cardiovascular diseases： updated review on heart failure progression [J]. Eur J Heart Fail，2020，19（3）：301-309.
[18] Okazaki H，Shirakabe A，Hata N，et al. New scoring system（APACHE-HF）for predicting adverse outcomes in patients with acute heart failure： Evaluation of the APACHEⅡ and Modified APACHEⅡ scoring systems [J]. J Cardiol，2014，64（6）：441-449.
[19] Wong DT，Knaus WA. Predicting outcome in critical care the current status of the APACHE prognostic scoring system [J]. Can J Anaesth，1991，38（3）：374-383.
[20] Maisel AS，Duran JM，Wettersten N. Natriuretic Peptides in Heart Failure Atrial and B-type Natriuretic Peptides [J]. Heart Fail Clin，2018，4（1）：13-25.
[21] Dhaliwal AS，Deswal A，Pritchett A，et al. Reduction in BNP Levels With Treatment of Decompensated Heart Failure and Future Clinical Events [J]. J Card Fail，2009，15（4）：293-299.
[22] Hammarsten O，Mair J，M?觟ckel M，et al. Possible mechanisms behind cardiac troponin elevations [J]. Biomarkers，2018，23（8）：725-734.
[23] Hayashi T，Hasegawa T，Kanzaki H，et al. Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure [J]. ESC Heart Fail，2016，3（3）：168-176.
[24] Vicinanza R，Coppotelli G，Malacrino C，et al. Oxidized Low-Density Lipoproteins Impair Endothelial Function by Inhibiting Non-Genomic Action of Thyroid Hormone–Mediated Nitric Oxide Production in Human Endothelial Cells [J]. Thyroid，2013，23（2）：231-238.
[25] de Castro AL，Tavares AV，Campos C，et al. Cardioprotective effects of thyroid hormones in a rat model of myocardial infarction are associated with oxidative stress reduction [J]. Mol Cell Endocrinol，2014，391（1/2）：22-29.